ARCHIVES

Schwetz Replaces Koski As HHS Human Research Protections Director

This article is from The Cancer Letter archive.

Vol. 29 No. 06 | February 7, 2003

Download PDF Visit The Full Archive

Related Articles

Conference On Delayed Consequences Of Cancer Therapy Scheduled Jan. 9-11

January 3, 1975

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

June 27, 2014

Insurance Co. Official Says Cancer Centers, Insurers Are “Allies”

June 2, 1995

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

October 29, 2010

More Debate Due On Organ Site Program; First Round Reviewed By DRG “Slaughtered”

January 28, 1983

ASCO Awards Contract For D.C Office

January 12, 1990